There is no general Therapeutic Use Exemption for these substances
This process depends on: Vitamin B6 (P5P) as an essential enzyme cofactor Adequate availability of glycine and glutamate Sufficient cellular energy (ATP) Proper liver and mitochondrial function When this pathway is inefficient, glutathione production may be impaired even if homocysteine, B12, or folate levels appear normal
Plus, it boosts how much of the active ingredient your body actually gets
There is also a condition called pernicious anaemia where your immune system prevents the cells in your stomach and gut from absorbing B12 from your food
Determining whether and how immune contributions concentrate on the common mTOR pathway in future studies will be critical for our understanding of the importance of mTOR in different aspects, not just from an immune perspective, as well as for future targeted drug development
Another study is testing how CagriSema works over longer periods and in people with higher body weights, with results expected around the first half of 2027